Alignment Healthcare Inc. Common Stock (ALHC)

FairStock Score: 34/100 — RISKY

Key Financials

Strengths

• Generates $234 million in annual free cash flow (5.5% yield on market cap)
• Solid return on equity of 12.5% above cost of capital
• Revenue growth of 44.4% demonstrates strong top-line momentum

Concerns

• Trades significantly above Graham Number ($1) with negative 1378% margin of safety—limited downside protection
• Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
• Weak Piotroski F-Score of 2/9 suggests deteriorating financial quality across multiple dimensions

AI Analysis

Alignment Healthcare Inc. Common Stock is a small-cap healthcare company valued at $4.3 billion. Revenue stands at $4.3 billion, though the company is currently unprofitable. From a quality standpoint, Alignment shows weak Piotroski F-Score of 2/9 signaling deteriorating fundamentals and Altman Z-Score of 2.9 in the grey zone. On valuation, the stock is commanding a steep 192.6x multiple, with trades far above its Graham Number ($1) with no margin of safety. Growth dynamics show revenue growing at 44.4% and profit growth of 64.6%. Our composite FairStock Score of 34/100 reflects below-average fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.

Bull Case

Alignment's 44% revenue growth trajectory could accelerate as it captures additional market share in the healthcare sector. With $234 million in annual free cash flow (5.5% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

At 193x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer